AU Stock MarketDetailed Quotes

LTP LTR Pharma Ltd

Watchlist
  • 0.810
  • 0.0000.00%
20min DelayNot Open Jul 11 16:00 AET
112.93MMarket Cap-81000P/E (Static)

LTR Pharma Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Jun 30, 2023
(FY)Jun 30, 2022
(FY)Jun 30, 2021
Operating cash flow (direct method)
Cash income from operating activities
9.08K
Other cash income from operating activities
----
--9.08K
----
Cash paid
-165.92%-1.54M
-1,886.00%-577.47K
-29.08K
Payments to suppliers for goods and services
-165.92%-1.54M
-1,886.00%-577.47K
---29.08K
Direct interest paid
25.93%-20
---27
----
Direct interest received
-62.18%90
2,063.64%238
--11
Operating cash flow
-170.25%-1.54M
-1,854.79%-568.18K
---29.07K
Investing cash flow
Cash flow from continuing investing activities
-1.99K
Net PPE purchase and sale
---1.99K
----
----
Cash from discontinued investing activities
Investing cash flow
---1.99K
----
----
Financing cash flow
Cash flow from continuing financing activities
-41.20%1.38M
1,214.46%2.34M
178.34K
Net issuance payments of debt
----
----
--350.12K
Net common stock issuance
-41.20%1.38M
2,175.93%2.34M
--103K
Net other financing activities
----
----
---274.78K
Cash from discontinued financing activities
Financing cash flow
-41.20%1.38M
1,214.46%2.34M
--178.34K
Net cash flow
Beginning cash position
1,205.48%1.91M
--146.41K
----
Current changes in cash
-108.96%-159.05K
1,089.78%1.78M
--149.27K
Effect of exchange rate changes
-113.69%-23.61K
-286.12%-11.05K
---2.86K
End cash Position
-9.56%1.73M
1,205.48%1.91M
--146.41K
Free cash from
-170.60%-1.54M
-1,854.79%-568.18K
---29.07K
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
(FY)Jun 30, 2023(FY)Jun 30, 2022(FY)Jun 30, 2021
Operating cash flow (direct method)
Cash income from operating activities 9.08K
Other cash income from operating activities ------9.08K----
Cash paid -165.92%-1.54M-1,886.00%-577.47K-29.08K
Payments to suppliers for goods and services -165.92%-1.54M-1,886.00%-577.47K---29.08K
Direct interest paid 25.93%-20---27----
Direct interest received -62.18%902,063.64%238--11
Operating cash flow -170.25%-1.54M-1,854.79%-568.18K---29.07K
Investing cash flow
Cash flow from continuing investing activities -1.99K
Net PPE purchase and sale ---1.99K--------
Cash from discontinued investing activities
Investing cash flow ---1.99K--------
Financing cash flow
Cash flow from continuing financing activities -41.20%1.38M1,214.46%2.34M178.34K
Net issuance payments of debt ----------350.12K
Net common stock issuance -41.20%1.38M2,175.93%2.34M--103K
Net other financing activities -----------274.78K
Cash from discontinued financing activities
Financing cash flow -41.20%1.38M1,214.46%2.34M--178.34K
Net cash flow
Beginning cash position 1,205.48%1.91M--146.41K----
Current changes in cash -108.96%-159.05K1,089.78%1.78M--149.27K
Effect of exchange rate changes -113.69%-23.61K-286.12%-11.05K---2.86K
End cash Position -9.56%1.73M1,205.48%1.91M--146.41K
Free cash from -170.60%-1.54M-1,854.79%-568.18K---29.07K
Accounting Standards US-GAAPUS-GAAPUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
AU
Overall
Symbol
Latest Price
%Chg